Your browser doesn't support javascript.
loading
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
Folegatti, Pedro M; Harrison, Kate; Preciado-Llanes, Lorena; Lopez, Fernando Ramos; Bittaye, Mustapha; Kim, Young Chan; Flaxman, Amy; Bellamy, Duncan; Makinson, Rebecca; Sheridan, Jonathan; Azar, Sasha R; Campos, Rafael Kroon; Tilley, Mark; Tran, Nguyen; Jenkin, Daniel; Poulton, Ian; Lawrie, Alison; Roberts, Rachel; Berrie, Eleanor; Rossi, Shannan L; Hill, Adrian; Ewer, Katie J; Reyes-Sandoval, Arturo.
Afiliación
  • Folegatti PM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Harrison K; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Preciado-Llanes L; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Lopez FR; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Bittaye M; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Kim YC; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Flaxman A; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Bellamy D; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Makinson R; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Sheridan J; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Azar SR; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Campos RK; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Tilley M; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Tran N; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Jenkin D; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Poulton I; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Lawrie A; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Roberts R; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Berrie E; Clinical Bio-manufacturing Facility, University of Oxford, Oxford, United Kingdom.
  • Rossi SL; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Hill A; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Ewer KJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Reyes-Sandoval A; The Jenner Institute, University of Oxford, Oxford, United Kingdom. arturo.reyes@ndm.ox.ac.uk.
Nat Commun ; 12(1): 4636, 2021 07 30.
Article en En | MEDLINE | ID: mdl-34330906
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas Virales / Virus Chikungunya / Anticuerpos Neutralizantes / Fiebre Chikungunya / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas Virales / Virus Chikungunya / Anticuerpos Neutralizantes / Fiebre Chikungunya / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido